Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 98

1.

Metallothionein - immunohistochemical cancer biomarker: a meta-analysis.

Gumulec J, Raudenska M, Adam V, Kizek R, Masarik M.

PLoS One. 2014 Jan 8;9(1):e85346. doi: 10.1371/journal.pone.0085346. eCollection 2014.

2.

Metallothionein stroma reaction in tumor adjacent healthy tissue in head and neck squamous cell carcinoma and breast adenocarcinoma.

Dutsch-Wicherek M, Popiela TJ, Klimek M, Rudnicka-Sosin L, Wicherek L, Oudinet JP, Skladzien J, Tomaszewska R.

Neuro Endocrinol Lett. 2005 Oct;26(5):567-74.

PMID:
16264399
3.

Hormone-receptor expression and ovarian cancer survival: an Ovarian Tumor Tissue Analysis consortium study.

Sieh W, Köbel M, Longacre TA, Bowtell DD, deFazio A, Goodman MT, Høgdall E, Deen S, Wentzensen N, Moysich KB, Brenton JD, Clarke BA, Menon U, Gilks CB, Kim A, Madore J, Fereday S, George J, Galletta L, Lurie G, Wilkens LR, Carney ME, Thompson PJ, Matsuno RK, Kjær SK, Jensen A, Høgdall C, Kalli KR, Fridley BL, Keeney GL, Vierkant RA, Cunningham JM, Brinton LA, Yang HP, Sherman ME, García-Closas M, Lissowska J, Odunsi K, Morrison C, Lele S, Bshara W, Sucheston L, Jimenez-Linan M, Driver K, Alsop J, Mack M, McGuire V, Rothstein JH, Rosen BP, Bernardini MQ, Mackay H, Oza A, Wozniak EL, Benjamin E, Gentry-Maharaj A, Gayther SA, Tinker AV, Prentice LM, Chow C, Anglesio MS, Johnatty SE, Chenevix-Trench G, Whittemore AS, Pharoah PD, Goode EL, Huntsman DG, Ramus SJ.

Lancet Oncol. 2013 Aug;14(9):853-62. doi: 10.1016/S1470-2045(13)70253-5. Epub 2013 Jul 9.

5.

Expression of metallothionein-1 and metallothionein-2 as a prognostic marker in hepatocellular carcinoma.

Park Y, Yu E.

J Gastroenterol Hepatol. 2013 Sep;28(9):1565-72. doi: 10.1111/jgh.12261.

PMID:
23662831
6.

HER3 overexpression and survival in solid tumors: a meta-analysis.

Ocana A, Vera-Badillo F, Seruga B, Templeton A, Pandiella A, Amir E.

J Natl Cancer Inst. 2013 Feb 20;105(4):266-73. doi: 10.1093/jnci/djs501. Epub 2012 Dec 8. Erratum in: J Natl Cancer Inst. 2013 Jul 3;105(13):944.

PMID:
23221996
7.

Glutathione levels in human tumors.

Gamcsik MP, Kasibhatla MS, Teeter SD, Colvin OM.

Biomarkers. 2012 Dec;17(8):671-91. doi: 10.3109/1354750X.2012.715672. Epub 2012 Aug 20. Review.

8.

Significance of CD44 expression in head and neck cancer: a systemic review and meta-analysis.

Chen J, Zhou J, Lu J, Xiong H, Shi X, Gong L.

BMC Cancer. 2014 Jan 13;14:15. doi: 10.1186/1471-2407-14-15. Review.

9.

Metallothionein expression in ovarian cancer in relation to histopathological parameters and molecular markers of prognosis.

Hengstler JG, Pilch H, Schmidt M, Dahlenburg H, Sagemüller J, Schiffer I, Oesch F, Knapstein PG, Kaina B, Tanner B.

Int J Cancer. 2001 Mar 20;95(2):121-7.

10.

Identification of bladder cancer patients at risk for recurrence or progression: an immunohistochemical study based on the expression of metallothionein.

Hinkel A, Schmidtchen S, Palisaar RJ, Noldus J, Pannek J.

J Toxicol Environ Health A. 2008;71(13-14):954-9. doi: 10.1080/15287390801989101.

PMID:
18569601
11.

The role of metallothionein in oncogenesis and cancer prognosis.

Pedersen MØ, Larsen A, Stoltenberg M, Penkowa M.

Prog Histochem Cytochem. 2009;44(1):29-64. doi: 10.1016/j.proghi.2008.10.001. Epub 2008 Dec 1. Review.

PMID:
19348910
12.

Metallothionein is up-regulated under hypoxia and promotes the survival of human prostate cancer cells.

Yamasaki M, Nomura T, Sato F, Mimata H.

Oncol Rep. 2007 Nov;18(5):1145-53.

PMID:
17914565
13.

Meta-analysis of the prognostic value of smad4 immunohistochemistry in various cancers.

Du Y, Zhou X, Huang Z, Qiu T, Wang J, Zhu W, Wang T, Liu P.

PLoS One. 2014 Oct 15;9(10):e110182. doi: 10.1371/journal.pone.0110182. eCollection 2014.

14.

Expression of metallothionein in colorectal cancers and synchronous liver metastases.

Hishikawa Y, Kohno H, Ueda S, Kimoto T, Dhar DK, Kubota H, Tachibana M, Koji T, Nagasue N.

Oncology. 2001;61(2):162-7.

PMID:
11528256
15.

SATB2 Expression Distinguishes Ovarian Metastases of Colorectal and Appendiceal Origin From Primary Ovarian Tumors of Mucinous or Endometrioid Type.

Moh M, Krings G, Ates D, Aysal A, Kim GE, Rabban JT.

Am J Surg Pathol. 2016 Mar;40(3):419-32. doi: 10.1097/PAS.0000000000000553.

PMID:
26551622
16.

Prognostic value of cancer stem cell marker aldehyde dehydrogenase in ovarian cancer: a meta-analysis.

Liu S, Liu C, Min X, Ji Y, Wang N, Liu D, Cai J, Li K.

PLoS One. 2013 Nov 25;8(11):e81050. doi: 10.1371/journal.pone.0081050. eCollection 2013.

17.

Lack of association of the TP53BP1 Glu353Asp polymorphism with risk of cancer: a systematic review and meta-analysis.

Liu L, Jiao J, Wang Y, Zhang D, Wu J, Huang D.

PLoS One. 2014 Mar 6;9(3):e90931. doi: 10.1371/journal.pone.0090931. eCollection 2014. Review.

18.

Correlation between the Uptake of 18F-Fluorodeoxyglucose (18F-FDG) and the Expression of Proliferation-Associated Antigen Ki-67 in Cancer Patients: A Meta-Analysis.

Deng SM, Zhang W, Zhang B, Chen YY, Li JH, Wu YW.

PLoS One. 2015 Jun 3;10(6):e0129028. doi: 10.1371/journal.pone.0129028. eCollection 2015.

19.

Adenoid cystic carcinoma of the salivary gland: a clinicopathological study of 49 cases and of metallothionein expression with regard to tumour behaviour.

Brazão-Silva MT, Cardoso SV, de Faria PR, Dias FL, Lima RA, Eisenberg AL, Nascimento MF, Loyola AM.

Histopathology. 2013 Dec;63(6):802-9. doi: 10.1111/his.12227. Epub 2013 Sep 19.

PMID:
24102890
20.

Metallothionein 2A expression and its relation to different clinical stages and grades of breast cancer in Egyptian patients.

Rezk NA, Zidan HE, Riad M, Mansy W, Mohamad SA.

Gene. 2015 Oct 15;571(1):17-22. doi: 10.1016/j.gene.2015.06.035. Epub 2015 Jun 18.

PMID:
26093198

Supplemental Content

Support Center